<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0265">
 <label>53</label>
 <element-citation publication-type="journal" id="rf0265">
  <person-group person-group-type="author">
   <name>
    <surname>Zhou</surname>
    <given-names>X.J.</given-names>
   </name>
   <name>
    <surname>Pietropaolo</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Sullivan-Bolyai</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mayers</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Safety and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <volume>55</volume>
  <year>2011</year>
  <fpage>76</fpage>
  <lpage>81</lpage>
  <pub-id pub-id-type="pmid">21060109</pub-id>
 </element-citation>
</ref>
